| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Review |
The Royal College of Surgeons in Ireland, Dublin, IRELAND (A.D.), Baltimore, Maryland
Division of Gastroenterology, Sinai Hospital of Baltimore and University of Maryland School of Medicine, Baltimore, Maryland (S.D.)
Address reprint requests to: Sudhir Dutta, M.D., Suite 51, Hoffeberger Prof. Center, 2435 W. Belvedere Avenue, Baltimore, MD 21215. E-mail: sudhirdutta{at}lifebridgehealth.org
Epidemiological and experimental studies suggest that antioxidants like vitamin E (
-tocopherol) may play an important role in prevention of chronic disease. Several observational surveys have linked populations with a large intake of vitamin E with reduced incidence of heart disease. These observations have been strengthened by the demonstration of strong antioxidant activity by vitamin E in cellular, molecular and animal experiments. These results have highlighted a potential role for vitamin E supplementation in the prevention of chronic disease in humans. Interestingly however, large-scale clinical trials of vitamin E and other antioxidants in preventing specific disease processes (e.g., coronary artery disease) have generated conflicting and mixed outcomes. In this review, the role of vitamin E in the prevention of atherosclerosis and carcinogenesis has been carefully examined with particular emphasis on salient human studies (clinical trials) and their limitations. In addition, pertinent biochemical, physiological and metabolic features of vitamin E have also been incorporated. A list of common natural food sources of vitamin E has been provided. Important in vitro and animal studies related to the antiatherosclerotic and anticarcinogenic actions of vitamin E have been discussed in detail. Finally, the direction of future investigations in primary and secondary prevention of chronic diseases by vitamin E supplementation has been outlined.
Key words: vitamin E, atherosclerosis, tocopherol, lipid peroxidation, carcinogenesis, heart disease
This article has been cited by other articles:
|
|
 |
|
  A. Y. H. Woo, M. M. Y. Waye, S. K. W. Tsui, S. T. W. Yeung, and C. H. K. Cheng Andrographolide Up-Regulates Cellular-Reduced Glutathione Level and Protects Cardiomyocytes against Hypoxia/Reoxygenation Injury J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 226 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L Rainwater, M. C Mahaney, J. L VandeBerg, and X. L. Wang Vitamin E dietary supplementation significantly affects multiple risk factors for cardiovascular disease in baboons Am. J. Clinical Nutrition, September 1, 2007; 86(3): 597 - 603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Chen and P. G. Wells Enhanced tumorigenesis in p53 knockout mice exposed in utero to high-dose vitamin E Carcinogenesis, July 1, 2006; 27(7): 1358 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Chajes, M. Cambot, K. Moreau, G. M. Lenoir, and V. Joulin Acetyl-CoA Carboxylase {alpha} Is Essential to Breast Cancer Cell Survival. Cancer Res., May 15, 2006; 66(10): 5287 - 5294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. van Breda, E. van Agen, S. van Sanden, T. Burzykowski, J. C. Kleinjans, and J. H. v. Delft Vegetables Affect the Expression of Genes Involved in Carcinogenic and Anticarcinogenic Processes in the Lungs of Female C57Bl/6 Mice J. Nutr., November 1, 2005; 135(11): 2546 - 2552. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
